Trial intelligence / Profile preview

Short course of amoxicillin for erysipelas (SHARE)

2008-006794-32Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of amoxicillin in erysipelas (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Clinical non-inferiority of 6-day oral amoxicillin vs 14-day standard regimen, Duration of fever and 1 more. Started May 2009; status: active.

02

Drugs

amoxicillin
03

Conditions

erysipelas

Beyond the preview

Go deeper on 2008-006794-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006794-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call